“…However, activation of NF-κB signaling via the alternative, or non-canonical, pathway has also been demonstrated to trigger mitochondrial biogenesis and to improve the metabolic capacity of skeletal muscle [ 63 , 64 ]. In the baseline differential expression pattern from ET individuals, we not only detected activation signatures for commonly approved transcriptional mediators of skeletal muscle endurance phenotype, like PPARG, TP53, and ESRRA [ 13 , 65 , 66 , 67 , 68 ], but also found indications for enhanced NF-κB activity. Although we cannot distinguish whether this reflects canonical or non-canonical signaling, increased expression of the anti-inflammatory enzyme IDO may hint at the latter [ 69 ].…”